The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding L3: Experience of Single Institute/ Baghdad
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 521
- 主要终点
- the relapse of childhood acute lymphoblastic leukemia in pediatric patients treated in the Child's Central Teaching Hospital/ Baghdad
研究概览
简要总结
Background: acute lymphoblastic leukemia is the most common childhood cancer and relapse is the main reason for treatment failure in childhood acute lymphoblastic leukemia.
The aim of this study: is to assess the relapse of childhood acute lymphoblastic leukemia in pediatric patients treated in the Child's Central Teaching Hospital/ Baghdad.
Methods: A retrospective study that reviewed 521 children with newly diagnosed ALL for children below 15 years during the period from 1st of January 2013 to 1st of March 2020 in the hemato-oncology ward in the Child's Central Teaching Hospital in Baghdad, with a total duration of follow-up for two years post last starting treatment (till 1st of March 2022 ).
详细描述
Six hundred patients diagnosed with acute lymphoblastic leukemia, seventy-nine patients were excluded from study, nine patients died very early before starting induction, seventy patients referred or starting treatment in another centers.
The medical history, laboratory data had been taken for patients including age, gender, residence, date of diagnosis, date of treatment, outcome of induction period and time of relapse, investigations at time of relapse, therapy and relapse outcome were carried out through chart analysis.
The initial diagnosis of ALL was done through bone marrow aspiration morphological classification of blast cells was performed according to the FAB method while immunophenotyping not done for all patients (not available in the period from 2013 to 2016( 227 cases not diagnosed by flowcytometry,294 cases diagnosed by flowcytometry), cytogenetic study not available in our country. The initial diagnostic screen (complete blood count and blood film, renal function test and serum electrolytes and serum uric acid, liver function tests, hepatitis screen, chest x ray, echo-study, computerized tomography and MRI done for indicated cases.
Risk group of patients at time of intial diagnosis divided into standard risk group (age between 1 years and 9.9 years and initial WBC count less than50000) and high risk group (age less than 1 and more than 10 years and WBC count more than 50000 and T cell leukemia) .
Patients regarded and treated as T cell leukemia either by flow cytometry or on clinical bases (mediastinal widening) which associated with(older age,high WBC count, lymphadenopathy, hepatosplenomegaly).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 2 Months 至 15 Years(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients diagnosed with acute lymphoplastic leukemia
排除标准
- •patients died before starting induction chemotherapy.
- •patients referred to another oncological center.
- •those who starting the treatment in another oncological center
结局指标
主要结局
the relapse of childhood acute lymphoblastic leukemia in pediatric patients treated in the Child's Central Teaching Hospital/ Baghdad
时间窗: the period from 1st of January 2013 to 1st of March 2020
521 children reviewed with newly diagnosed ALL for children below 15 years
次要结局
未报告次要终点
研究者
Maha Kharbat Shadhar Al-Magsoosi
doctor
Central Teaching Hospital of Peadiatrics, Baghdad
